Correction to: Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial

被引：0
|
作者：
Hiroaki Seino
机构：
[1] Seino Internal Medical Clinic,
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2807 / 2811
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial
    Takazono, Takahiro
    Hosogaya, Naoki
    Fukushima, Koki
    Morio, Ryosuke
    Irifune, Satoshi
    Miyamura, Takuto
    Harada, Yosuke
    Nagayoshi, Yosuke
    Kondo, Akira
    Mihara, Tomo
    Fukuda, Yuichi
    Sasaki, Eisuke
    Sawai, Toyomitsu
    Imamura, Yoshifumi
    Morikawa, Toru
    Futsuki, Yoji
    Inoue, Yuichi
    Fukushima, Kiyoyasu
    Suyama, Naofumi
    Tanaka, Hikaru
    Hanaka, Tetsuya
    Shimabukuro, Ikuko
    Hata, Ryosuke
    Ota, Kenji
    Morimoto, Shimpei
    Nakada, Nana
    Ito, Yuya
    Yoshida, Masataka
    Takeda, Kazuaki
    Ide, Shotaro
    Iwanaga, Naoki
    Nemoto, Kazuki
    Funada, Midori
    Izumikawa, Koichi
    Yatera, Kazuhiro
    Yanagihara, Katsunori
    Mukae, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (07) : 597 - 602
  • [22] Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases: A multicentre, open-label and single-arm clinical trial
    Sun, Xuefeng
    Li, Ping
    Lin, Hongli
    Ni, Zhaohui
    Zhan, Yongli
    Cai, Guangyan
    Liu, Chao
    Chen, Qinkai
    Wang, Wenge
    Wang, Xiaoqin
    Zhang, Peiqing
    Li, Peng
    Liang, Meng
    Zheng, Hongguang
    Wang, Niansong
    Miao, Lining
    Jin, Ruixia
    Guo, Zhiyong
    Wang, Yong
    Chen, Xiangmei
    PHYTOMEDICINE, 2022, 99
  • [23] Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma
    Kilgour, James M.
    Shah, Aatman
    Urman, Nicole M.
    Eichstadt, Shaundra
    Do, Hanh N.
    Bailey, Irene
    Mirza, Amar
    Li, Shufeng
    Oro, Anthony E.
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4717 - 4725
  • [24] Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
    Kjetil Boye
    Alessandra Longhi
    Tormod Guren
    Susanne Lorenz
    Stine Næss
    Michela Pierini
    Ingeborg Taksdal
    Ingvild Lobmaier
    Marilena Cesari
    Anna Paioli
    Ayca M. Løndalen
    Elisabetta Setola
    Ivar Hompland
    Leonardo A. Meza-Zepeda
    Kirsten Sundby Hall
    Emanuela Palmerini
    Cancer Immunology, Immunotherapy, 2021, 70 : 2617 - 2624
  • [25] Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
    Boye, Kjetil
    Longhi, Alessandra
    Guren, Tormod
    Lorenz, Susanne
    Naess, Stine
    Pierini, Michela
    Taksdal, Ingeborg
    Lobmaier, Ingvild
    Cesari, Marilena
    Paioli, Anna
    Londalen, Ayca M.
    Setola, Elisabetta
    Hompland, Ivar
    Meza-Zepeda, Leonardo A.
    Hall, Kirsten Sundby
    Palmerini, Emanuela
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2617 - 2624
  • [26] A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
    Hirota, Yushi
    Kakei, Yasumasa
    Imai, Junta
    Katagiri, Hideki
    Ebihara, Ken
    Wada, Jun
    Suzuki, Junichi
    Urakami, Tatsuhiko
    Omori, Takashi
    Ogawa, Wataru
    DIABETES THERAPY, 2024, 15 (02) : 533 - 545
  • [27] A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
    Yushi Hirota
    Yasumasa Kakei
    Junta Imai
    Hideki Katagiri
    Ken Ebihara
    Jun Wada
    Junichi Suzuki
    Tatsuhiko Urakami
    Takashi Omori
    Wataru Ogawa
    Diabetes Therapy, 2024, 15 : 533 - 545
  • [28] Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
    Yap, Timothy A.
    Nakagawa, Kazuhiko
    Fujimoto, Nobukazu
    Kuribayashi, Kozo
    Guren, Tormod Kyrre
    Calabro, Luana
    Shapira-Frommer, Ronnie
    Gao, Bo
    Kao, Steven
    Matos, Ignacio
    Planchard, David
    Chatterjee, Arkendu
    Jin, Fan
    Norwood, Kevin
    Kindler, Hedy L.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (06): : 613 - 621
  • [29] Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial
    Zhao, Yi
    Zhang, Xu
    Jin, Chenxing
    Yu, Xiaomin
    Zhang, Min
    Cao, Yang
    Li, Ying
    Wang, Aman
    Shan, Xiu
    Zhang, Jia
    Wang, Juhong
    Yin, Liu
    Tan, Xiaoxin
    Liu, Jiwei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 3277 - 3285
  • [30] Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure
    Fujisue, Koichiro
    Ito, Miwa
    Matsuzawa, Yasushi
    Arima, Yuichiro
    Takashio, Seiji
    Sueta, Daisuke
    Araki, Satoshi
    Hanatani, Shinsuke
    Yamanaga, Kenshi
    Yamamoto, Masahiro
    Kaneko, Shozo
    Yamamoto, Eiichiro
    Matsushita, Kenichi
    Soejima, Hirofumi
    Tsujita, Kenichi
    CIRCULATION REPORTS, 2024, 6 (03) : 55 - 63
12345